Irena Motovich
About Irena Motovich
Irena Motovich is a Start Up, Regional Clinical Operation professional at Bristol Myers Squibb with over a decade of experience in clinical operations and regulatory affairs.
Current Role at Bristol Myers Squibb
Irena Motovich currently holds the position of Start Up, Regional Clinical Operation at Bristol Myers Squibb. Joining the company in November 2020, she brings over a decade of experience in clinical operations and regulatory affairs. Her role involves overseeing clinical trial start-ups and ensuring that operations align with regional regulatory requirements.
Professional Background in Clinical Operations
Irena Motovich has a comprehensive background in clinical operations. She spent nearly a decade at PPD in various roles, starting as an SI&A Country Approval Specialist from 2011 to 2014. She then served as a Senior Start Up Submission Specialist for one year before transitioning to a Start Up CRA. Between 2015 and 2020, Irena progressed from Start Up CRA (level II) to Senior Start Up CRA (level I), gaining deep insights into clinical trial initiation and regulatory submissions.
Experience at Meir Medical Center
Prior to her tenure at PPD, Irena Motovich worked as an IRB Coordinator at Meir Medical Center from 2010 to 2011. In this role, she coordinated Institutional Review Board activities, ensuring that clinical trials met ethical standards and regulatory requirements.
Educational Background in Biotechnology and Healthcare Administration
Irena Motovich studied at Bar-Ilan University, where she achieved a Bachelor of Applied Science (B.A.Sc.) in Biotechnology. She furthered her studies by obtaining a Master’s degree in Healthcare Administration (MHA) from the same institution. Her robust educational background supports her extensive experience in clinical operations and regulatory affairs.
Expertise in Clinical Trial Start-Ups and Submissions
Over the years, Irena Motovich has developed significant expertise in clinical trial start-ups and submissions. This includes her work at PPD, where she handled various aspects of clinical trial initiation and regulatory submissions. Her deep knowledge in this field is further supported by her current role at Bristol Myers Squibb, where she continues to contribute to the field of clinical operations.